110 related articles for article (PubMed ID: 36857183)
1. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression.
Zhang Y; He B; Zhang D; Zhang Y; Chen C; Zhang W; Yang S; Yao M; Cui G; Gu J; Wang T; Lin Z; Fan Y; Xiong Z; Hao Y
Cell Rep; 2023 Mar; 42(3):112188. PubMed ID: 36857183
[TBL] [Abstract][Full Text] [Related]
2. p85β regulates autophagic degradation of AXL to activate oncogenic signaling.
Rao L; Mak VCY; Zhou Y; Zhang D; Li X; Fung CCY; Sharma R; Gu C; Lu Y; Tipoe GL; Cheung ANY; Mills GB; Cheung LWT
Nat Commun; 2020 May; 11(1):2291. PubMed ID: 32385243
[TBL] [Abstract][Full Text] [Related]
3. Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer.
Hao Y; He B; Wu L; Li Y; Wang C; Wang T; Sun L; Zhang Y; Zhan Y; Zhao Y; Markowitz S; Veigl M; Conlon RA; Wang Z
Nat Commun; 2022 Apr; 13(1):1974. PubMed ID: 35418124
[TBL] [Abstract][Full Text] [Related]
4. FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade.
Kuchay S; Duan S; Schenkein E; Peschiaroli A; Saraf A; Florens L; Washburn MP; Pagano M
Nat Cell Biol; 2013 May; 15(5):472-80. PubMed ID: 23604317
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K).
Ito Y; Hart JR; Ueno L; Vogt PK
Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16826-9. PubMed ID: 25385636
[TBL] [Abstract][Full Text] [Related]
6. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
7. Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma.
Zhang J; Gelman IH; Qu J; Hochwald SN
Oncogene; 2023 Feb; 42(6):449-460. PubMed ID: 36513743
[TBL] [Abstract][Full Text] [Related]
8. Selenoprotein S regulates tumorigenesis of clear cell renal cell carcinoma through AKT/ GSK3β/NF-κB signaling pathway.
Mao H; Zhao Y; Lei L; Hu Y; Zhu H; Wang R; Ni D; Liu J; Xu L; Xia H; Zhang Z; Ma M; Pan Z; Zhou Q; Xie Y
Gene; 2022 Jul; 832():146559. PubMed ID: 35569765
[TBL] [Abstract][Full Text] [Related]
9. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
10. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
[TBL] [Abstract][Full Text] [Related]
11. The 'New (Nu)-clear' evidence for the tumor-driving role of PI3K.
Pozo FM; Hunter T; Zhang Y
Acta Mater Med; 2022; 1(2):193-196. PubMed ID: 37200937
[TBL] [Abstract][Full Text] [Related]
12. Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.
Harlander S; Schönenberger D; Toussaint NC; Prummer M; Catalano A; Brandt L; Moch H; Wild PJ; Frew IJ
Nat Med; 2017 Jul; 23(7):869-877. PubMed ID: 28553932
[TBL] [Abstract][Full Text] [Related]
13. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
14. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
15. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
Guo C; Sah JF; Beard L; Willson JK; Markowitz SD; Guda K
Genes Chromosomes Cancer; 2008 Nov; 47(11):939-46. PubMed ID: 18663744
[TBL] [Abstract][Full Text] [Related]
16. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
18. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity.
Li Y; Anderson DH; Liu Q; Zhou Y
J Biol Chem; 2008 Aug; 283(34):23397-409. PubMed ID: 18534979
[TBL] [Abstract][Full Text] [Related]
20. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.
Li G; Ci W; Karmakar S; Chen K; Dhar R; Fan Z; Guo Z; Zhang J; Ke Y; Wang L; Zhuang M; Hu S; Li X; Zhou L; Li X; Calabrese MF; Watson ER; Prasad SM; Rinker-Schaeffer C; Eggener SE; Stricker T; Tian Y; Schulman BA; Liu J; White KP
Cancer Cell; 2014 Apr; 25(4):455-68. PubMed ID: 24656772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
